Testing for respiratory pathogens using comprehensive multiplex molecular panels has become a valuable diagnostic tool to assist in early identification of causative organisms. Appropriate use supports timely and directed antimicrobial therapy, especially for organisms that cannot be cultured routinely (e.g Mycoplasma, Legionella, Chlamydophila, Bordetella and viruses); decreases in-hospital admission rate, length of hospital stay, and also assists in antimicrobial stewardship by avoiding the use of empiric antimicrobial agents.
BioFire Filmarray Syndromic Panels